Latest Publications

@article{kummer_estrogenic_2008,

title = {Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats.},

author = {Vladimír Kummer and Jarmila Masková and Zdenek Zralý and Jirí Neca and Pavlína Simecková and Jan Vondrácek and Miroslav Machala},

doi = {10.1016/j.toxlet.2008.06.862},

issn = {0378-4274},

year  = {2008},

date = {2008-08-01},

journal = {Toxicology letters},

volume = {180},

number = {3},

pages = {212–221},

abstract = {Polycyclic aromatic hydrocarbons (PAHs) are an important group of environmental pollutants, known for their mutagenic and carcinogenic activities. Many PAHs are aryl hydrocarbon receptor (AhR) ligands and several recent studies have suggested that PAHs or their metabolites may activate estrogen receptors (ER). The present study investigated possible estrogenic/antiestrogenic effects of abundant environmental contaminants benzo[a]pyrene (BaP), benz[a]anthracene (BaA), fluoranthene (Fla) and benzo[k]fluoranthene (BkF) in vivo, using the immature rat uterotrophic assay. The present results suggest that BaA, BaP and Fla behaved as estrogen-like compounds in immature Wistar rats, when applied for 3 consecutive days at 10mg/kg/day, as documented by a significant increase of uterine weight and hypertrophy of luminal epithelium. These effects were likely to be mediated by ERalpha, a major subtype of ER present in uterus, as they were inhibited by treatment with ER antagonist ICI 182,780. BaA, the most potent of studied PAHs, induced a significant estrogenic effect within a concentration range 0.1-50mg/kg/day; however, it did not reach the maximum level induced by reference estrogens. The proposed antiestrogenicity of the potent AhR agonist BkF was not confirmed in the present in vivo study; the exposure to BkF did not significantly affect the uterine weight, although a weak suppression of ERalpha immunostaining was observed in luminal and glandular epithelium, possibly related to its AhR-mediated activity. The PAHs under study did not induce marked genotoxic damage in uterine tissues, as documented by the lack of Ser-15-phoshorylated p53 protein staining. With the exception of Fla, all three remaining compounds increased CYP1-dependent monooxygenation activities in liver at the doses used, suggesting that the potential tissue-specific antiestrogenic effects of PAHs mediated by metabolization of 17beta-estradiol also cannot be excluded. Taken together, these environmentally relevant PAHs induced estrogenic effects in vivo, which might affect their toxic impact and carcinogenicity.},

note = {Place: Netherlands},

keywords = {Animals, Cytochrome P-450 CYP1A1/metabolism, Endocrine Disruptors/*toxicity, Environmental Pollutants/*toxicity, Epithelium/drug effects, Estradiol/metabolism, Estrogen Receptor alpha/metabolism, Estrogens/*biosynthesis, Female, Hydroxylation, Immunohistochemistry, Liver/drug effects/metabolism, Microsomes, Organ Size/drug effects, Ovary/drug effects, Phosphorylation, Polycyclic Aromatic Hydrocarbons/*toxicity, Rats, Tumor Suppressor Protein p53/metabolism, Uterus/drug effects/*metabolism, Wistar},

pubstate = {published},

tppubtype = {article}

}

@article{forejtnikova_chemoprotective_2005,

title = {Chemoprotective and toxic potentials of synthetic and natural chalcones and dihydrochalcones in vitro.},

author = {Hana Forejtníková and Kamila Lunerová and Renata Kubínová and Dagmar Jankovská and Radek Marek and Radovan Kares and Václav Suchý and Jan Vondrácek and Miroslav Machala},

doi = {10.1016/j.tox.2004.11.011},

issn = {0300-483X},

year  = {2005},

date = {2005-03-01},

journal = {Toxicology},

volume = {208},

number = {1},

pages = {81–93},

abstract = {Cytochrome P4501A activity, oxidative stress and inhibition of gap junctional intercellular communication (GJIC) are involved in metabolic activation of promutagens and tumor-promoting activity of various xenobiotics, and their prevention is considered to be an important characteristic of chemoprotective compounds. In this study, a series of 31 chalcones and their corresponding dihydroderivatives, substituted in 2,2'-, 3,3'-, 4- or 4'-position by hydroxyl or methoxy group, were tested for their ability to inhibit Fe(II)/NADPH-enhanced lipid peroxidation and cytochrome P4501A-dependent 7-cethoxyresorufin-O-deethylase (EROD) activity in rat hepatic microsomes. Effects of the compounds on GJIC were determined in rat liver epithelial WB-F344 cells. Most of the chalcones and dihydrochalcones inhibited EROD activity in a dose-dependent manner at the range 0.25-25 microM, which was comparable to model flavonoid inhibitors alpha-naphthoflavone and quercetin. The chalcones exhibited higher inhibition activity than the corresponding dihydroderivatives. Mono and dihydroxylated chalcones, and dihydrochalcones showed none or only a weak antioxidant activity; trihydroxyderivatives inhibited in vitro lipid peroxidation significantly only at 50 microM concentration. Potential adverse effects, namely inhibition of GJIC and/or cytotoxicity were detected after treatment of WB-F344 cells with a number of chalcone and dihydrochalcone derivatives, suggesting that they should be excluded from additional screening as chemoprotective compounds. Chalcones and dihydrochalcones substituted at 4- and/or 4'-position, which elicited no inhibition of GJIC, were further tested for the potential enhancing effects on GJIC. The present data seem to suggest that 4-hydroxy, 2',4'-dihydroxy-3-methoxy, 2,4,4'-trihydroxy, and 2',4,4'-trihydroxychalcone, 2',4-dihydroxy and 2'-hydroxy-3,4-dimethoxydihydrochalcone might be promising chemoprotective compounds against CYP1A activity, and partly also against oxidative damage without inducing adverse effects, such as GJIC inhibition. In general, determination of potencies of tested compounds to inhibit GJIC should be involved in any set of methods for the in vitro screening of chemoprotective characteristics of potential drugs, in order to reveal their potential adverse effects associated with tumor promotion.},

note = {Place: Ireland},

keywords = {Animals, Carcinogens/metabolism/*toxicity, Cell Communication/drug effects/physiology, Cell Line, Chalcones/*pharmacology/*toxicity, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Enzyme System/*metabolism, Dose-Response Relationship, Drug, Epithelial Cells/drug effects/metabolism, Gap Junctions/drug effects/metabolism/physiology, In Vitro Techniques, Lipid Peroxidation/drug effects, Liver/drug effects/enzymology, Liver/drug effects/ultrastructure, Male, Microsomes, Rats, Structure-Activity Relationship, Wistar},

pubstate = {published},

tppubtype = {article}

}